1. Home
  2. SCKT vs VIVS Comparison

SCKT vs VIVS Comparison

Compare SCKT & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Socket Mobile Inc.

SCKT

Socket Mobile Inc.

N/A

Current Price

$1.33

Market Cap

9.5M

Sector

Technology

ML Signal

N/A

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$1.90

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCKT
VIVS
Founded
1992
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
8.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SCKT
VIVS
Price
$1.33
$1.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.5K
36.4K
Earning Date
02-24-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,945,490.00
$140,000.00
Revenue This Year
$8.62
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.92
52 Week Low
$0.82
$1.41
52 Week High
$1.63
$21.96

Technical Indicators

Market Signals
Indicator
SCKT
VIVS
Relative Strength Index (RSI) 77.44 44.41
Support Level $1.00 $1.98
Resistance Level $1.26 $2.18
Average True Range (ATR) 0.04 0.15
MACD 0.03 0.01
Stochastic Oscillator 96.77 14.29

Price Performance

Historical Comparison
SCKT
VIVS

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: